Expert Tips and Advice for Women's Health

Providence Swedish North offers free STOP THE BLEED® training

Providence Swedish North is offering free STOP THE BLEED® training at Providence Regional Medical Center Everett.

Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

10/30/2024

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

New studies test immunotherapy to boost breast cancer treatment and prevent return

10/30/2024

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Attend a free virtual symposium on melanoma, Oct. 25

10/8/2024

Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

Understanding seasonal affective disorder (SAD)

11/4/2024

Don’t get SAD. An expert at Providence answers common questions to help you understand seasonal affective disorder.

Providence Swedish earns national recognitions from American Heart Association

8/29/2024

The awards highlight Providence Swedish's consistency in following the American Heart Association's guidelines for care, treatment and improved outcomes in stroke and diabetes.

Navigating your journey through menopause

10/18/2024

Menopause is a natural aging process for roughly half the population. Learn how to navigate the journey from perimenopause to menopause and beyond.

2024 Hood to Coast Relay: Providence team captains tell us why they run

8/22/2024

What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

Providence Community Cancer Screening Event

Targeting cancer cells: Two studies take different approaches

6/26/2024

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

The evolution of cancer immunotherapy: Dr. Urba shares his insights

6/28/2024

Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

Cancer survivorship: A guide to living with and beyond cancer

6/11/2024

June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

Radiation oncologist discusses MRI-guided radiation therapy for pancreatic cancer

8/9/2024

Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

Cancer studies seek to harness the power of the immune system

5/29/2024

Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.

Celebrating World Immunology Day

4/26/2024

Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

Providence St. Joseph Hospital in Orange officially opens the Helen Caloggero Women’s and Family Center

4/18/2024

Sprawling multi-million dollar facility in Orange County is a one-stop location to access full-suite of women’s health, mother-baby services and more

New vaccine being studied for HPV+ head and neck cancer

5/7/2024

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

Providing support for Black mothers beyond the traditional “healthy mom, healthy baby” approach

7/23/2024

At Providence, we recognize the importance of providing holistic care and comprehensive prenatal, labor and delivery, and postpartum support for Black birthing parents and babies.

Celebrating our oncology social workers

3/25/2024

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

Talking to an expert: The crucial role of nutrition in cancer care

3/19/2024

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

How promoting apoptosis in new study may help people with cancer

3/21/2024

In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

Endometriosis: Separating truths from misconceptions

3/4/2024

Learn the truth about endometriosis, including the symptoms, treatments and more in this comprehensive guide from Providence.

Dose-escalation studies aspire to fill gaps in cancer treatment options

2/26/2024

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

FDA approves cellular therapy, offering hope to more people with cancer

3/6/2024

The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).

Celebrating Women in Science

5/3/2024

In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.

Virtual education: Food and common cancer myths

3/14/2024

Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.

Why regular health checks are vital for women in their 40s

1/27/2024

Did you know that women in their 40s are at a higher risk of developing certain health conditions, such as breast cancer, diabetes, high blood pressure, and osteoporosis?

Promising results of amivantamab studies appear in high-profile journals

3/13/2024

New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.

A remarkable year of engagement and advancements at Providence Cancer Institute

1/10/2024

Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.

Meet Dr. Anderson: At home in Hood River, on a trail, beach or mountaintop

12/13/2023

Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.